Acquired resistance to the PRMT5 inhibitor confers collateral sensitivity to MEK inhibition in MTAP-null non-small cell lung cancer
- DOI
- 10.64898/2026.04.16.719008
- Published
- 2026-04-21
- Container
- Not recorded
- Publisher
- openRxiv
- Open access
- unknown
Credibility signals
uncertain Score 60/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- cautionPublication version: Identified as a preprint; peer review and later versions may change the record.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.64898/2026.04.16.719008,
title = {Acquired resistance to the PRMT5 inhibitor confers collateral sensitivity to MEK inhibition in MTAP-null non-small cell lung cancer},
author = {Rongjie Fu and Yalong Wang and Ishita Rehman and Ella Bedford and Sana Sharif and Nghi D. Nguyen and Reid T. Powell and Andrew Adams and Weijun Liu and Shuyue Wang and Wei He and Yue Lu and Bin Liu and Pooja Anil Shah and Jordi Rodon Ahnert and Taiping Chen and Weiyi Peng and Clifford C. Stephan and Xinli Liu and Mark T. Bedford and Han Xu},
year = {2026},
doi = {10.64898/2026.04.16.719008},
url = {https://doi.org/10.64898/2026.04.16.719008}
}RIS
TY - JOUR TI - Acquired resistance to the PRMT5 inhibitor confers collateral sensitivity to MEK inhibition in MTAP-null non-small cell lung cancer AU - Rongjie Fu AU - Yalong Wang AU - Ishita Rehman AU - Ella Bedford AU - Sana Sharif AU - Nghi D. Nguyen AU - Reid T. Powell AU - Andrew Adams AU - Weijun Liu AU - Shuyue Wang AU - Wei He AU - Yue Lu AU - Bin Liu AU - Pooja Anil Shah AU - Jordi Rodon Ahnert AU - Taiping Chen AU - Weiyi Peng AU - Clifford C. Stephan AU - Xinli Liu AU - Mark T. Bedford AU - Han Xu PY - 2026 DO - 10.64898/2026.04.16.719008 UR - https://doi.org/10.64898/2026.04.16.719008 ER -
APA
Fu, R., Wang, Y., Rehman, I., Bedford, E., Sharif, S., Nguyen, N. D., Powell, R. T., Adams, A., Liu, W., Wang, S., He, W., Lu, Y., Liu, B., Shah, P. A., Ahnert, J. R., Chen, T., Peng, W., Stephan, C. C., Liu, X., Bedford, M. T., & Xu, H. (2026). Acquired resistance to the PRMT5 inhibitor confers collateral sensitivity to MEK inhibition in MTAP-null non-small cell lung cancer. https://doi.org/10.64898/2026.04.16.719008
Source records
- crossref · retrieved 2026-09-26T17:10:24.619Z